Intrinsic Value of S&P & Nasdaq Contact Us

Aligos Therapeutics, Inc. ALGS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.00
+133.9%

Aligos Therapeutics, Inc. (ALGS) has 8 identified peers for comparison in the Healthcare sector. Peers include ACHL, ASMB, CTMX, NLTX, NUVB, NXTC and others.

ALGS has a market capitalization of $52.91M, compared to an average peer market cap of $405.29M. ALGS is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message